15 November 2024 Mesoblast Limited (MSB) Results of Annual General Meeting Held 15 November 2024 In accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001 (Cth), we advise details of the resolutions and the proxies received in respect of each resolution as per the attached report. All resolutions were passed and decided by way of a poll. Release authorized by the Chief Executive. Yours faithfully Niva Sivakumar Company Secretary Exhibit 99.4

ANNUAL GENERAL MEETING Friday, 15 November, 2024 MESOBLAST LIMITED Short Description For Against For Against Abstain ** As required by section 251AA(2) of the Corporations Act 2001 (Commonwealth) the following statistics are provided in respect of each resolution on the agenda. Resolution Voted on at the meeting Total votes cast in the poll (where applicable) Abstain Result Discretionary (open votes) No Strike Y/N/NA Proxy Votes (as at proxy close) RESULT OF ANNUAL GENERAL MEETING (ASX REPORT) 347,641,785 1,098,53150,768,33602 ADOPTION OF THE REMUNERATION REPORT 2,542,294 1,098,531 49,830,936 336,256,107 12.74%87.26% Carried 86.52% 12.82% 0.65% N 468,886,464 1,095,3749,028,58903 RE-ELECTION OF DR PHILIP KRAUSE AS A DIRECTOR 2,662,363 1,095,374 8,973,589 456,498,317 1.89%98.11% Carried 97.51% 1.92% 0.57% NA 461,692,463 853,79716,460,76104 PROPOSED ISSUE OF SHARES TO CHIEF MEDICAL OFFICER, DR ERIC ROSE, FOR HIS PARTICIPATION IN THE CAPITAL RAISING 2,512,434 513,552 15,327,732 450,872,519 3.44%96.56% Carried 96.19% 3.27% 0.54% NA 367,883,148 590,73131,034,77305A PROPOSED ISSUE OF OPTIONS TO DR SILVIU ITESCU IN CONNECTION WITH HIS LONG-TERM INCENTIVE REMUNERATION FOR THE 2024/2025 FINANCIAL YEAR 2,500,374 590,731 29,758,962 356,877,801 7.78%92.22% Carried 91.71% 7.65% 0.64% NA 371,657,475 417,45927,433,71805B PROPOSED ISSUE OF OPTIONS TO DR SILVIU ITESCU IN LIEU OF 30% OF BASE SALARY 2,541,709 417,459 26,486,318 360,282,382 6.87%93.13% Carried 92.54% 6.80% 0.65% NA 344,353,177 1,005,33654,150,13905C PROPOSED ISSUE OF OPTIONS TO DR SILVIU ITESCU IN CONNECTION WITH HIS SHORT-TERM INCENTIVE REMUNERATION FOR THE 2022/2023 AND 2023/2024 FINANCIAL YEARS 2,550,374 1,005,336 51,724,733 334,447,425 13.59%86.41% Carried 86.04% 13.31% 0.66% NA 369,147,025 571,64629,789,98106A PROPOSED ISSUE OF OPTIONS TO DR ERIC ROSE IN CONNECTION WITH HIS LONG-TERM INCENTIVE REMUNERATION FOR THE 2024/2025 FINANCIAL YEAR 2,500,374 571,646 28,691,581 357,964,267 7.47%92.53% Carried 91.98% 7.37% 0.64% NA 371,555,923 526,10427,426,62506B PROPOSED ISSUE OF OPTIONS TO DR ERIC ROSE IN LIEU OF 30% OF BASE SALARY 2,508,384 526,104 26,479,225 360,214,155 6.87%93.13% Carried 92.55% 6.80% 0.64% NA 344,856,343 494,15054,158,15906C PROPOSED ISSUE OF OPTIONS TO DR ERIC ROSE IN CONNECTION WITH HIS SHORT-TERM INCENTIVE REMUNERATION FOR THE 2022/2023 AND 2023/2024 FINANCIAL YEARS 2,502,874 494,150 51,595,306 335,135,538 13.57%86.43% Carried 86.10% 13.26% 0.64% NA 369,596,129 545,73029,366,79307A PROPOSED ISSUE OF MILESTONE-BASED OPTIONS TO DR PHILIP KRAUSE IN CONNECTION WITH HIS CONSULTANCY FEES FOR THE 2024/2025 FINANCIAL YEAR 2,534,634 545,730 28,353,304 358,294,200 7.36%92.64% Carried 92.06% 7.29% 0.65% NA Printed: 15/11/2024 Page 1 of 2This report was produced from the Link Market Services Meeting System

ANNUAL GENERAL MEETING Friday, 15 November, 2024 MESOBLAST LIMITED Short Description For Against For Against Abstain ** As required by section 251AA(2) of the Corporations Act 2001 (Commonwealth) the following statistics are provided in respect of each resolution on the agenda. Resolution Voted on at the meeting Total votes cast in the poll (where applicable) Abstain Result Discretionary (open votes) No Strike Y/N/NA Proxy Votes (as at proxy close) RESULT OF ANNUAL GENERAL MEETING (ASX REPORT) 374,320,061 589,39624,599,19507B PROPOSED ISSUE OF TIME-BASED OPTIONS TO DR PHILIP KRAUSE IN CONNECTION WITH HIS CONSULTANCY FEES 2,527,134 569,396 22,279,878 364,351,460 6.17%93.83% Carried 93.63% 5.73% 0.65% NA 370,040,310 1,054,12728,413,21508 PROPOSED ISSUE OF OPTIONS TO INDEPENDENT NON-EXECUTIVE DIRECTORS 2,527,134 1,054,127 26,817,159 359,328,448 7.13%92.87% Carried 92.45% 6.90% 0.65% NA 260,561,950 37,014,57924,894,92209 RATIFICATION OF ISSUE OF SECURITIES TO INSTITUTIONAL INVESTORS 2,535,763 36,514,579 22,799,016 250,841,309 8.72%91.28% Carried 90.83% 8.26% 0.92% NA 281,304,444 36,523,6694,643,33810A RATIFICATION OF GRANT OF WARRANTS RELATED TO CONVERTIBLE NOTE FINANCING 2,690,870 35,813,659 4,643,338 269,542,800 1.62%98.38% Carried 97.35% 1.68% 0.97% NA 279,653,458 36,651,7886,166,20510B PROPOSED ISSUE OF SECURITIES RELATED TO CONVERTIBLE NOTE FINANCING 2,678,220 35,941,778 6,166,205 267,904,464 2.16%97.84% Carried 96.80% 2.23% 0.97% NA 473,676,759 2,664,2042,670,05811 RENEWAL OF PROPORTIONAL TAKEOVER APPROVAL PROVISIONS IN THE COMPANYS CONSTITUTION 2,686,999 2,407,325 2,670,058 461,465,855 0.56%99.44% Carried 98.85% 0.57% 0.58% NA ** - Note that votes relating to a person who abstains on an item are not counted in determining whether or not the required majority of votes were cast for or against that item Printed: 15/11/2024 Page 2 of 2This report was produced from the Link Market Services Meeting System